Newsroom

Deciding on a Chemistry, Manufacturing and Control Strategy for Biologic Development

MANUFACTURING CHEMIST

Khanh Ngo Courtney from Avomeen discusses what biopharmaceutical companies should keep in mind as they embark on their CMC journey ...
CONTINUE READING

Media Coverage | 08.30.2021

HOT MELT EXTRUSION – API Bioavailability: Suspending Hydrophobic Drugs in a Solid Solution

DRUG DEVELOPMENT & DELIVERY

As defined in the International Conference on Harmonization (ICH) Guidance for Industry, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical ...
CONTINUE READING

Press Release | 08.30.2021

Avomeen Appoints New Head of Formulation & Clinical Trial Manufacturing

ANN ARBOR, MICH. Avomeen recently announced Alex Garner as its new Director of Formulation and Clinical Trial Manufacturing. In this position, Garner ...
CONTINUE READING

Media Coverage | 08.01.2021

Picking the Perfect Method Development Partner

PHARMTECH

There are some key questions that should be asked by both the sponsor company and the outsourcing partner before undertaking ...
CONTINUE READING

Media Coverage | 07.01.2021

Can CDMOs Provide Leadership in Cell and Gene Therapy?

BIOPROCESS INTERNATIONAL

We interviewed industry experts at FUJIFILM Diosynth Biotechnoloogies, Avomeen, and Intellia Therapeutics, Inc. about the unique ways CDMOs participate in ...
CONTINUE READING

Media Coverage | 06.29.2021

What Upheaval Taught Us: Science Marketing Experts on Lessons from the Pandemic

C&EN BRANDLAB

The COVID-19 pandemic put science in the global spotlight. Science marketing experts reflect on lessons from the past year ...
CONTINUE READING

Press Release | 06.23.2021

Avomeen Recognized with Special Tribute by the State of Michigan

Avomeen, a Michigan-based CRO/CDMO, was recognized by the State of Michigan on May 20, 2021 with a Special Tribute for ...
CONTINUE READING

Media Coverage | 06.22.2021

Outlining the Key Steps to Method Development

PHARMTECH

Thought and foresight into method development stages can ensure costly errors and delays are avoided later on. Method development is ...
CONTINUE READING

Media Coverage | 06.14.2021

Hot Melt Extrusion: Enhancing the Bioavailability of Hydrophobic Drugs

MANUFACTURING CHEMIST

It’s necessary for a drug substance to be present in a dissolved state to achieve the desired concentration in systemic ...
CONTINUE READING

Let’s work together to achieve your vision

Ready to get started? Click Get a Quote, or talk to an expert first if you’d like help in defining your project scope.

Get a quote

AVOMEEN IS NOW PART OF LEARN MORE

Newsroom

Let’s work together to achieve your vision

AVOMEEN IS NOW PART OF
LEARN MORE